Sterling
GSK logo
GSK
Sanofi logo
Sanofi

Revenue Comparison

Chart: Revenue Comparison. Values in USD billions. In Q2 2026: GSK 10.595, Sanofi 13.284.

GSK vs Sanofi Net Worth and Market Cap

GSK (GSK) and Sanofi (SNY) are peers in Vaccines. GSK reported revenue of $10.6B as of Q2 2026, compared with $13.3B for Sanofi. Sanofi leads on revenue.

GSK's gross margin is 73.0% versus 75.5% for Sanofi. GSK's net margin is 5.2% versus 2.8% for Sanofi.

Key differences

  • Revenue growth from Q2 2025 to Q2 2026: Sanofi +14.6%, GSK +5.3%.
  • Sanofi keeps more of its revenue as operating profit: a 19.4% operating margin, against 5.7% at GSK.
  • GSK's KPIs on Sterling include Arexvy Sales by Region (Quarterly) and HIV Franchise Sales (Quarterly).
  • Sanofi's KPIs on Sterling include Beyfortus Net Sales (Quarterly) and Dupixent Net Sales by Region (Quarterly).

Latest Quarter Comparison

Table: Latest Quarter Comparison. 15 rows across Metric, GSK, Sanofi.
MetricGSKSanofi
Market Cap--
Revenue$10.60B$13.28B
Cost of Revenue$2.85B$3.26B
Gross Profit$7.74B$10.03B
Operating Income$606.00M$2.58B
Net Income$548.00M$370.00M
R&D Expense$4.37B$2.41B
Earnings Per Share$0.28$0.15
Gross Margin73.0%75.5%
Operating Margin5.7%19.4%
Net Profit Margin5.2%2.8%
Free Cash Flow$2.78B$4.22B
Cumulative Free Cash Flow$157.21B$51.81B
Operating Cash Flow$3.19B$5.85B
Cash & Equivalents$3.89B$6.86B

Ask Sterling

Register for a premium account to gain access to Sterling AI.

Get Started

Things you can ask Sterling:

Summarize Tesla's latest earnings reportWhy did NVIDIA's margins expand?Compare Apple vs Microsoft's cash flowWhat's driving EV industry growth?
Menu
Favorites